Table 7.
Demographics of study cohort.
| Category | Demographic group | Total patients | |
|---|---|---|---|
| N | % | ||
| Total | Total | 283 | 100.0% |
| Age | Under 5 years | 16 | 5.7% |
| 5–17 years | 16 | 5.7% | |
| 18–24 years | 16 | 5.7% | |
| 25–44 years | 72 | 25.4% | |
| 45–64 years | 95 | 33.6% | |
| 65 years and above | 68 | 24.0% | |
| Missing | 0 | 0.0% | |
| Gender | Male | 72 | 25.4% |
| Female | 210 | 74.2% | |
| Unknown | 1 | 0.4% | |
| Race | White | 167 | 59.0% |
| Black or African American | 37 | 13.1% | |
| Asian/Pacific Islander | 10 | 3.5% | |
| American Indian or Alaska Native | 3 | 1.1% | |
| Other | 38 | 13.4% | |
| Unknown | 28 | 9.9% | |
| Declined to answer | 0 | 0.0% | |
| Ethnicity | Hispanic | 29 | 10.2% |
| Non-Hispanic | 223 | 78.8% | |
| Unknown | 31 | 11.0% | |
| Immunization type | COVID-19 | 249 | 88.0% |
| Pneumococcal conjugate PCV 13 | 9 | 3.2% | |
| Tdap | 8 | 2.8% | |
| MMRV | 4 | 1.4% | |
| Unspecified | 3 | 2.1% | |
| Meningococcal MCV4O | 1 | 0.4% | |
| Influenza | 6 | 2.1% | |